"Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"

Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07578246

Enrollment

Registered

2026-05-11

Start date

2026-06-01

Completion date

2028-07-01

Last updated

2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LAZMAR Scoring , Hysteroscopic Myomectomy

Brief summary

This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.

Detailed description

This study aims to evaluate the applicability of LASMAR scoring in predicting surgical outcomes for cases of hysteroscopic myomectomy. By applying the LASMAR scoring system to patient , the study seeks to determine if the scoring can accurately predict operative time, completeness of resection, and complication rates.

Interventions

PROCEDUREHysteroscopic Myomectomy

Hysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids).

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Inclusion criteria

* Women aged 18-45 years * Type 0,1,2 Fibroids according to Figo classification. * Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss. * Fibroids size ≤ 5 cm in diameter * Confirmed diagnosis of leiomyoma by ultrasound . * Hemodynamically Stable Patients: Patients with no significant anemia.

Exclusion criteria

* Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection) * Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis). * Cases requiring concurrent procedures (e.g., Laparoscopic surgeries). * Fibroid Size\>5 cm.

Design outcomes

Primary

Measure	Time frame	Description
Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications.	2 years	Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications

Secondary

Measure	Time frame	Description
Postoperative Complications: Including infection, adhesions, volume overload.	2 years	Postoperative Complications: Including infection, adhesions, volume overload.
Need for Further Interventions: Incidence of additional treatments like hormonal therapy	2 years	Need for Further Interventions: Incidence of additional treatments like hormonal therapy

Contacts

CONTACTYomna Ayman Salah, Master degree

yomnasalah@med.asu.edu.eg01060666006

CONTACTAhmed Mohammed Selim, MD

011 15330063

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026